Summary

KEY FINDINGS
The North America insulin patch pumps market is expected to register an 11.09% CAGR during the assessment period, 2023-2032. Growing healthcare expenditure and rising per capita income are expected to drive market growth in the region.
MARKET INSIGHTS
The North America insulin patch pumps market growth assessment includes an analysis of Canada and the United States. Canada boasts a wealth of internationally recognized diabetes researchers, building upon the remarkable legacy of the Canadian discovery of insulin many years ago. Through strategic collaboration with various partners and investments in health research, the Government of Canada remains committed to advancing the prevention, diagnosis, and treatment of all forms of diabetes.
Canada’s contributions to advances in diabetes prevention and treatment are noteworthy, given that the government of Canada reports over 3 million people with diagnosed diabetes, and the prevalence rate has been increasing at an average rate of 3.3% per year after adjusting for the aging population. The growing prevalence of diabetes and rising investments in healthcare research and development are anticipated to propel the market growth during the forecast period.
COMPETITIVE INSIGHTS
Key market players include Tandem Diabetes Care Inc, Insulet Corporation, Medtronic PLC, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1.RESEARCH SCOPE & METHODOLOGY
1.1.STUDY OBJECTIVES
1.2.METHODOLOGY
1.3.ASSUMPTIONS & LIMITATIONS
2.EXECUTIVE SUMMARY
2.1.MARKET SIZE & ESTIMATES
2.2.MARKET OVERVIEW
2.3.SCOPE OF STUDY
2.4.CRISIS SCENARIO ANALYSIS
2.5.MAJOR MARKET FINDINGS
2.5.1.RISING OCCURRENCE OF DIABETES
2.5.2.GROWING HEALTHCARE AWARENESS
2.5.3.TECHNOLOGICAL ADVANCEMENTS IN INSULIN DELIVERY SYSTEMS
2.5.4.INCREASING RESEARCH AND DEVELOPMENT IN MEDICAL DEVICES
3.MARKET DYNAMICS
3.1.KEY DRIVERS
3.1.1.GROWING PREVALENCE OF DIABETES
3.1.2.TECHNOLOGICAL ADVANCEMENTS IN INSULIN PATCH PUMPS
3.1.3.RISING AWARENESS ABOUT PATCH PUMPS
3.2.KEY RESTRAINTS
3.2.1.STRINGENT GOVERNMENT REGULATIONS
3.2.2.RISKS ASSOCIATED WITH THE USE OF PUMPS
3.2.3.LACK OF KNOWLEDGE LIMITS THE ADOPTION
4.KEY ANALYTICS
4.1.PARENT MARKET ANALYSIS
4.2.KEY TECHNOLOGY TRENDS
4.3.PORTER’S FIVE FORCES ANALYSIS
4.3.1.BUYERS POWER
4.3.2.SUPPLIERS POWER
4.3.3.SUBSTITUTION
4.3.4.NEW ENTRANTS
4.3.5.INDUSTRY RIVALRY
4.4.GROWTH PROSPECT MAPPING
4.5.MARKET MATURITY ANALYSIS
4.6.MARKET CONCENTRATION ANALYSIS
4.7.VALUE CHAIN ANALYSIS
4.7.1.RESEARCH AND DEVELOPMENT
4.7.2.PRODUCT MANUFACTURING
4.7.3.SALES AND DISTRIBUTION
4.8.KEY BUYING CRITERIA
4.8.1.COST
4.8.2.PRODUCT FEATURES
4.8.3.USABILITY
5.MARKET BY TYPE
5.1.DISPOSABLE
5.2.REUSABLE
6.MARKET BY DELIVERY MODE
6.1.BASAL
6.2.BOLUS
6.3.BASAL & BOLUS
7.MARKET BY DISEASE INDICATION
7.1.TYPE 1 DIABETES
7.2.TYPE 2 DIABETES
8.MARKET BY DISTRIBUTION CHANNEL
8.1.HOSPITAL PHARMACIES
8.2.RETAIL PHARMACIES
8.3.ONLINE PHARMACIES
9.GEOGRAPHICAL ANALYSIS
9.1.NORTH AMERICA
9.1.1.MARKET SIZE & ESTIMATES
9.1.2.NORTH AMERICA INSULIN PATCH PUMPS MARKET DRIVERS
9.1.3.NORTH AMERICA INSULIN PATCH PUMPS MARKET CHALLENGES
9.1.4.NORTH AMERICA INSULIN PATCH PUMPS MARKET REGULATORY FRAMEWORK
9.1.5.KEY PLAYERS IN NORTH AMERICA INSULIN PATCH PUMPS MARKET
9.1.6.COUNTRY ANALYSIS
9.1.6.1.UNITED STATES
9.1.6.1.1.UNITED STATES INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
9.1.6.2.CANADA
9.1.6.2.1.CANADA INSULIN PATCH PUMPS MARKET SIZE & OPPORTUNITIES
10.COMPETITIVE LANDSCAPE
10.1.KEY STRATEGIC DEVELOPMENTS
10.1.1.ACQUISITIONS
10.1.2.PRODUCT LAUNCHES & DEVELOPMENTS
10.1.3.PARTNERSHIPS & AGREEMENTS
10.2.COMPANY PROFILES
10.2.1.CEQUR SA
10.2.1.1.COMPANY OVERVIEW
10.2.1.2.PRODUCTS / SERVICES LIST
10.2.1.3.STRENGTHS & CHALLENGES
10.2.2.DEBIOTECH SA
10.2.2.1.COMPANY OVERVIEW
10.2.2.2.PRODUCTS / SERVICES LIST
10.2.2.3.STRENGTHS & CHALLENGES
10.2.3.EOFLOW CO LTD
10.2.3.1.COMPANY OVERVIEW
10.2.3.2.PRODUCTS / SERVICES LIST
10.2.3.3.STRENGTHS & CHALLENGES
10.2.4.F. HOFFMANN-LA ROCHE LTD
10.2.4.1.COMPANY OVERVIEW
10.2.4.2.PRODUCTS / SERVICES LIST
10.2.4.3.STRENGTHS & CHALLENGES
10.2.5.INSULET CORPORATION
10.2.5.1.COMPANY OVERVIEW
10.2.5.2.PRODUCTS / SERVICES LIST
10.2.5.3.STRENGTHS & CHALLENGES
10.2.6.MEDTRONIC PLC
10.2.6.1.COMPANY OVERVIEW
10.2.6.2.PRODUCTS / SERVICES LIST
10.2.6.3.STRENGTHS & CHALLENGES
10.2.7.MEDTRUM TECHNOLOGIES INC
10.2.7.1.COMPANY OVERVIEW
10.2.7.2.PRODUCTS / SERVICES LIST
10.2.7.3.STRENGTHS & CHALLENGES
10.2.8.TANDEM DIABETES CARE INC
10.2.8.1.COMPANY OVERVIEW
10.2.8.2.PRODUCTS / SERVICES LIST
10.2.8.3.STRENGTHS & CHALLENGES
10.2.9.TERUMO CORPORATION
10.2.9.1.COMPANY OVERVIEW
10.2.9.2.PRODUCTS / SERVICES LIST
10.2.9.3.STRENGTHS & CHALLENGES